Cargando…
Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727403/ https://www.ncbi.nlm.nih.gov/pubmed/36505807 http://dx.doi.org/10.3389/fonc.2022.1081632 |
| _version_ | 1784845010672287744 |
|---|---|
| author | Pinton, Giulia Wang, Zhuo Balzano, Cecilia Missaglia, Sara Tavian, Daniela Boldorini, Renzo Fennell, Dean A. Griffin, Martin Moro, Laura |
| author_facet | Pinton, Giulia Wang, Zhuo Balzano, Cecilia Missaglia, Sara Tavian, Daniela Boldorini, Renzo Fennell, Dean A. Griffin, Martin Moro, Laura |
| author_sort | Pinton, Giulia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9727403 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97274032022-12-08 Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition Pinton, Giulia Wang, Zhuo Balzano, Cecilia Missaglia, Sara Tavian, Daniela Boldorini, Renzo Fennell, Dean A. Griffin, Martin Moro, Laura Front Oncol Oncology Frontiers Media S.A. 2022-11-23 /pmc/articles/PMC9727403/ /pubmed/36505807 http://dx.doi.org/10.3389/fonc.2022.1081632 Text en Copyright © 2022 Pinton, Wang, Balzano, Missaglia, Tavian, Boldorini, Fennell, Griffin and Moro https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Pinton, Giulia Wang, Zhuo Balzano, Cecilia Missaglia, Sara Tavian, Daniela Boldorini, Renzo Fennell, Dean A. Griffin, Martin Moro, Laura Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition |
| title | Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition |
| title_full | Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition |
| title_fullStr | Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition |
| title_full_unstemmed | Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition |
| title_short | Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition |
| title_sort | corrigendum: cdkn2a determines mesothelioma cell fate to ezh2 inhibition |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727403/ https://www.ncbi.nlm.nih.gov/pubmed/36505807 http://dx.doi.org/10.3389/fonc.2022.1081632 |
| work_keys_str_mv | AT pintongiulia corrigendumcdkn2adeterminesmesotheliomacellfatetoezh2inhibition AT wangzhuo corrigendumcdkn2adeterminesmesotheliomacellfatetoezh2inhibition AT balzanocecilia corrigendumcdkn2adeterminesmesotheliomacellfatetoezh2inhibition AT missagliasara corrigendumcdkn2adeterminesmesotheliomacellfatetoezh2inhibition AT taviandaniela corrigendumcdkn2adeterminesmesotheliomacellfatetoezh2inhibition AT boldorinirenzo corrigendumcdkn2adeterminesmesotheliomacellfatetoezh2inhibition AT fennelldeana corrigendumcdkn2adeterminesmesotheliomacellfatetoezh2inhibition AT griffinmartin corrigendumcdkn2adeterminesmesotheliomacellfatetoezh2inhibition AT morolaura corrigendumcdkn2adeterminesmesotheliomacellfatetoezh2inhibition |